IDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IDA is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is close to its pivot level, technical momentum is mixed to slightly weak, there is no supportive news catalyst, and both AI Stock Picker and SwingMax show no buy signal today. Analyst sentiment is generally constructive, but the current setup does not justify an immediate aggressive entry. Based on the provided data, the clear call is to hold and wait for a better setup rather than buy now.
IDA is trading pre-market at 138.61, slightly below the pivot of 139.48. The MACD histogram is negative at -0.488 and still below zero, which points to weak short-term momentum. RSI_6 at 45.2 is neutral, so the stock is neither oversold nor showing strong upside pressure. Moving averages are converging, suggesting a consolidating pattern rather than a confirmed uptrend. Support is at 135.874 and 133.646, while resistance is at 143.086 and 145.314. The short-term pattern data also leans cautious, with a projected -2.44% next week and -6.45% next month.
["Barclays raised its price target to $167 and kept an Overweight rating, calling Idaho Corp's growth prospects the best and accelerating versus the group.", "Mizuho raised its price target to $157 and kept an Outperform rating.", "The broader analyst tone remains constructive, with multiple firms maintaining Overweight/Outperform views.", "Utilities have recently shown relative strength versus the S&P in analyst commentary, which supports the sector backdrop."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "AI Stock Picker shows no signal on the stock today.", "SwingMax shows no signal recently.", "MACD remains negative and momentum is still weak.", "The stock is trading just below pivot resistance, limiting immediate upside confirmation.", "Short-term pattern analysis suggests downside over the next week and month.", "Hedge funds and insiders are both neutral with no notable buying trends.", "No recent congress trading data is available.", "No financial snapshot could be assessed due to missing data."]
No usable latest-quarter financial snapshot was available in the provided data, so I cannot evaluate revenue or earnings growth for the most recent quarter. The latest available seasonal context is not provided either, limiting assessment of quarter-specific operating momentum.
Analyst sentiment is mostly positive. Barclays and Mizuho both raised price targets in early May 2026, and Barclays reiterated an Overweight rating with the view that IDA has the best and accelerating growth prospects in its peer group. Morgan Stanley also remains constructive with Overweight ratings, though it made small target adjustments. The main counterpoint is Wells Fargo's Underweight rating, but the broader Wall Street view is still more bullish than bearish.
